Faculty

Josh Lutfig

2026 Sessions

Prescribing and Deprescribing in High-Risk Situations: Navigating Benzos, Stimulants, and Substance Use Disorders

Psychiatric clinicians frequently encounter complex prescribing decisions involving controlled substances, comorbid substance use, and competing clinical priorities. This session examines evidence-based approaches to prescribing and deprescribing benzodiazepines, stimulants, and other high-risk medications while balancing symptom management, safety, and patient-centered care. Faculty will review risk assessment strategies, monitoring considerations, withdrawal management, and practical approaches to challenging clinical scenarios commonly encountered in psychiatric practice.

Speaker

Saturday, December 05 10:00–11:00 AM
Faculty

Josh Lutfig

Faculty

Arwen Podesta

MD, DFAPA, DFASAM
Psychiatrist
Podesta Wellness

Boarded in Psychiatry, Addiction Medicine, Forensic Psychiatry and Holistic & Integrative Medicine, Arwen Podesta MD works in Louisiana, with an office in New Orleans. She authored a book on addiction, HOOKED (available on Amazon, see her website, www.podestawellness.com). She was recently awarded the honor of distinguished fellow of the American Psychiatry Association as well as the American Society of Addiction Medicine and is the immediate past President of the Louisiana Psychiatric Medical Association. She consults to the Louisiana governor’s HOPE committee and is a member of the Attorney General’s Opioid Abatement Taskforce. She is a national speaker, she teaches, consults and is an advocate for integrative best practices for those with addiction and psychiatric needs.

Cross-Titration and Deprescribing in Psychiatric Practice: A Case-Based Approach

Medication transitions are common in psychiatric care but can present significant challenges related to symptom destabilization, withdrawal effects, and patient concerns. This interactive workshop focuses on evidence-based approaches to cross-titration, medication tapering, and deprescribing in complex clinical situations. Through case-based discussion, faculty will examine common scenarios involving antidepressants, antipsychotics, benzodiazepines, and other psychotropic medications while providing practical tools to support safe and effective medication management.

Speaker

Saturday, December 05 2:40–3:40 PM
Faculty

Rebecca Barbee

MSPAS, PA-C, CAQ-Psych
Physician Assistant
Southlake Psychiatry

Rebecca Kraus Barbee, PA-C, CAQ-Psych is a board-certified Physician Assistant specializing in psychiatry at Southlake Psychiatry in Davidson, North Carolina. With advanced certification in psychiatry (CAQ-Psych), she is deeply engaged in the clinical management of complex mood and anxiety disorders, with particular expertise in psychopharmacology, novel antidepressant therapies, and treatment-resistant depression.

Rebecca is an active national speaker and educator, frequently presenting on emerging therapies, anhedonia, major depressive disorder, bipolar disorder recognition, and innovative treatment strategies. She is passionate about translating clinical trial data into practical, evidence-based strategies that improve patient outcomes. In addition to her clinical practice, she has contributed to media discussions on mental health awareness and is committed to advancing education for fellow clinicians through conference presentations and collaborative academic initiatives.

She is an active member of the Association of PAs in Psychiatry, AAPA, and NCAPA, and is dedicated to elevating the role of Physician Assistants in psychiatric care through leadership, education, and advocacy.

Faculty

Josh Lutfig

Back to top